Lowey Dannenberg, P.C. is investigating Fulgent Genetics, Inc. for potential violations of federal securities laws following the company's disclosure of a slight revenue shortfall in 2025 and a sequential decline in fourth-quarter revenue. The investigation invites investors who suffered losses to contact the firm for possible legal action. This development highlights concerns about Fulgent's financial reporting and may lead to legal consequences if violations are confirmed.
The official $HODL coin, created by GameKyuubi—the original author of the famous 2013 "HODL" post—has expanded to Ethereum with a new 1:1 cross-chain bridge powered by LayerZero. This bridge allows holders to transfer $HODL tokens instantly between S...
The Boulder County Business Hall of Fame revealed its 2026 inductees, honoring seven influential figures from sectors like education, finance, law, immigrant entrepreneurship, and real estate. The inductees include Sandy and Sally Bracken, Gerry Agne...
Breckenridge Distillery, a subsidiary of Tilray Brands, won top awards at the San Francisco World Spirits Competition. Their Rum Cask Finish received the highest honor, Double Gold with 97 points, while their Honey Whiskey earned a Gold medal. These ...
The global laboratory equipment services market, valued at $28.94 billion in 2025, is projected to grow to $62.83 billion by 2035 at an 8% CAGR. Growth is fueled by increased R&D investments, stricter regulatory compliance, and expanding biopharma an...
Reklaim Credit Solutions, a credit rating agency for the state-regulated cannabis industry, announced that co-founders Sam Fensterstock and Bob McCarthy have taken on executive roles as Chief Revenue Officer and Chief Technology Officer, respectively...
